Pharmacologic studies have revealed that cysteinyl leukotrienes (CYSLTs) act through two receptors, cysteinyl leukotriene receptor 1 (CYSLTR1) and CYSLTR2. CYSLTR1 antagonists are widely used to treat asthma and rhinitis. In this study, we characterized the genomic structure and transcriptional regulation of CYSLTR1 and examined associations between CYSLTR1 polymorphisms and asthma/rhinitis. The experiment of rapid amplification of cDNA end revealed that CYSLTR1 contains three exons and that the entire open reading frame is located in exon 3. Reverse transcriptase-polymerase chain reaction showed that there were multiple splice variants of CYSLTR1 and that the transcript expression patterns differed from tissues and cell types. The promoter region of CYSLTR1 is from -665 to -30 bp relative to the transcription start site. We identified four polymorphisms (c.-618-434T/C, c.-618-275C/A, c.-618-136G/A, and 927C/T), and transmission disequilibrium tests revealed that none of these polymorphisms was associated with the development of asthma/rhinitis. However, the TCG and CAA haplotypes in the promoter region caused different transcriptional activity. Our findings indicate that CYSLTR1 polymorphisms are not likely to be involved in the development of asthma/rhinitis, but it is possible that these polymorphisms could influence drug responses in individuals with atopic diseases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1399-3038.2005.00347.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antiviral and Immunomodulatory Effects of Zafirlukast Against Flaviviruses via Inhibition of the TNF Signaling Pathway.
J Med Virol
January 2025
Infection and Immunity Research Strength, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Selangor, Malaysia.
The two most clinically important members of the flavivirus genus, Zika virus (ZIKV) and dengue virus (DENV) pose a significant public health challenge. They cause a range of diseases in humans, from hemorrhagic to neurological manifestations, leading to economic and social burden worldwide. Nevertheless, there are no approved antiviral drugs to treat these infections.
View Article and Find Full Text PDFCysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy.
Invest Ophthalmol Vis Sci
November 2024
Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States.
Purpose: Diabetic macular edema (DME) is the primary cause of vision impairment in diabetic retinopathy (DR) patients. A previous study has shown the efficacy of montelukast, a cysteinyl leukotriene receptor (CysLTR)1 antagonist, in a diabetic mouse model. This study aims to understand the CysLTR1 signaling in retinal endothelial cells and the impact of montelukast.
View Article and Find Full Text PDFCYSLTR1 antagonism displays potent anti-tumor effects in uveal melanoma.
Exp Eye Res
November 2024
Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada; The MUHC - McGill University Ocular Pathology & Translational Research Laboratory, Montreal, QC, Canada.
Article Synopsis
- * The study investigates the expression of the CYSLTR1 receptor in 31 human UM samples and shows that it is highly expressed in both primary and metastatic UM cells.
- * Blocking CYSLTR1 with the drug MK571 reduces UM cell growth and metabolic activity while increasing cell death, suggesting that targeting this receptor could be a promising treatment strategy for UM.
Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.
J Ocul Pharmacol Ther
December 2024
Department of Ophthalmology, Anatomy & Neurobiology, Neuroscience Institute, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Article Synopsis
- Montelukast is a medicine that helps with asthma and allergies by blocking certain signals in the body that cause inflammation.
- New research shows that Montelukast might also help with other serious problems like heart disease, cancer, and eye diseases.
- The review looks at how Montelukast works in different diseases and checks to see if it can help people with vision problems.
The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence.
Sci Signal
September 2024
Laboratory of Chemical Biology and Signal Transduction, Rockefeller University, New York, NY 10065, USA.
Article Synopsis
- Melanoma caused by sun exposure differs from rarer types of melanocytic tumors, which have fewer mutations and allow researchers to explore specific signaling mechanisms.
- Uveal melanoma and blue nevi are examples of these rarer tumors, often linked to mutations in a particular signaling pathway involving G protein-coupled receptors.
- The study highlights how the same mutations can lead to cell growth in one tissue while hindering growth in another, illustrating how the tissue environment influences cell behavior and balance between growth and aging.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!